484
Participants
Start Date
September 30, 2003
Study Completion Date
November 30, 2006
Gefitinib or Docetaxel
Research Site, Nagoya
Research Site, Okazaki
Research Site, Hirosaki
Research Site, Kashiwa
Research Site, Matsuyama
Research Site, Fukuoka
Research Site, Gifu
Research Site, Asahikawa
Research Site, Sapporo
Research Site, Akashi
Research Site, Kobe
Research Site, Naka-gun
Research Site, Isehara
Research Site, Sagamihara
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Sendai
Research Site, Nagasaki
Research Site, Ōmura
Research Site, Niigata
Research Site, Beppu
Research Site, Okayama
Research Site, Habikino
Research Site, Izumisano
Research Site, Osaka
Research Site, Sakai
Research Site, Sayama
Research Site, Toyonaka
Research Site, Iwata
Research Site, Sunto-gun
Research Site, Bunkyo-ku
Research Site, Chūō
Research Site, Kiyose
Research Site, Minato-ku
Research Site, Shinjuku
Research Site, Sumida City
Research Site, Toshima-ku
Research Site, Yamagata
Research Site, Ube
Research Site, Kanazawa
Lead Sponsor
AstraZeneca
INDUSTRY